CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 217 filers reported holding CHEMOCENTRYX INC in Q3 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,653,448,000 | +110.8% | 70,721 | +1.1% | 0.00% | +100.0% |
| Q2 2022 | $1,733,434,000 | +0.2% | 69,953 | +1.4% | 0.00% | 0.0% |
| Q1 2022 | $1,729,378,000 | -39.5% | 68,982 | -12.2% | 0.00% | 0.0% |
| Q4 2021 | $2,860,298,000 | +139.5% | 78,558 | +12.5% | 0.00% | – |
| Q3 2021 | $1,194,127,000 | -4.2% | 69,832 | -25.0% | 0.00% | -100.0% |
| Q2 2021 | $1,246,141,000 | -59.0% | 93,065 | +56.8% | 0.00% | 0.0% |
| Q1 2021 | $3,040,581,000 | -15.7% | 59,340 | +1.9% | 0.00% | -50.0% |
| Q4 2020 | $3,606,593,000 | +37.0% | 58,246 | +21.3% | 0.00% | +100.0% |
| Q3 2020 | $2,631,607,000 | -5.3% | 48,022 | -0.6% | 0.00% | -50.0% |
| Q2 2020 | $2,778,895,000 | +76.7% | 48,295 | +23.4% | 0.00% | +100.0% |
| Q1 2020 | $1,572,484,000 | -15.5% | 39,136 | -16.9% | 0.00% | 0.0% |
| Q4 2019 | $1,861,738,000 | +667.3% | 47,073 | +31.5% | 0.00% | – |
| Q3 2019 | $242,643,000 | +20.5% | 35,788 | +65.4% | 0.00% | – |
| Q2 2019 | $201,280,000 | -4.6% | 21,643 | +29.6% | 0.00% | – |
| Q3 2018 | $211,088,000 | -4.0% | 16,700 | 0.0% | 0.00% | – |
| Q2 2018 | $219,939,000 | – | 16,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |